Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics Statistics

Total Valuation

CDTX has a market cap or net worth of $6.91 billion. The enterprise value is $6.49 billion.

Market Cap	6.91B
Enterprise Value	6.49B

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CDTX has 31.44 million shares outstanding. The number of shares has increased by 229.65% in one year.

Current Share Class	31.44M
Shares Outstanding	31.44M
Shares Change (YoY)	+229.65%
Shares Change (QoQ)	+72.91%
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	77.84%
Float	23.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	15.26
P/TBV Ratio	16.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.00.

Current Ratio	4.62
Quick Ratio	4.40
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.70% and return on invested capital (ROIC) is -36.75%.

Return on Equity (ROE)	-68.70%
Return on Assets (ROA)	-29.35%
Return on Invested Capital (ROIC)	-36.75%
Return on Capital Employed (ROCE)	-37.82%
Revenue Per Employee	n/a
Profits Per Employee	-$4.86M
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1,075.76% in the last 52 weeks. The beta is 1.55, so CDTX's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	+1,075.76%
50-Day Moving Average	120.37
200-Day Moving Average	57.99
Relative Strength Index (RSI)	88.25
Average Volume (20 Days)	2,174,504

Short Selling Information

The latest short interest is 3.30 million, so 10.49% of the outstanding shares have been sold short.

Short Interest	3.30M
Short Previous Month	3.20M
Short % of Shares Out	10.49%
Short % of Float	14.27%
Short Ratio (days to cover)	2.21

Income Statement

Revenue	n/a
Gross Profit	-131.82M
Operating Income	-159.91M
Pretax Income	-184.80M
Net Income	-184.74M
EBITDA	-159.78M
EBIT	-159.91M
Earnings Per Share (EPS)	-$11.11

Balance Sheet

The company has $420.02 million in cash and $1.98 million in debt, giving a net cash position of $418.04 million or $13.30 per share.

Cash & Cash Equivalents	420.02M
Total Debt	1.98M
Net Cash	418.04M
Net Cash Per Share	$13.30
Equity (Book Value)	422.39M
Book Value Per Share	14.40
Working Capital	346.98M

Cash Flow

Operating Cash Flow	-132.94M
Capital Expenditures	n/a
Free Cash Flow	-132.94M
FCF Per Share	-$4.23

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CDTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-229.65%
Shareholder Yield	-229.65%
Earnings Yield	-2.67%
FCF Yield	-1.92%

Analyst Forecast

The average price target for CDTX is $119.44, which is -45.65% lower than the current price. The consensus rating is "Buy".

Price Target	$119.44
Price Target Difference	-45.65%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	240.71%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 24, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Apr 24, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

CDTX has an Altman Z-Score of 1.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.34
Piotroski F-Score	2